AI assistant
TOMPKINS FINANCIAL CORP — Director's Dealing 2015
Feb 20, 2015
32217_dirs_2015-02-20_ec7332ed-0a70-4026-a554-99a8ebdcc819.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TOMPKINS FINANCIAL CORP (TMP)
CIK: 0001005817
Period of Report: 2015-02-19
Reporting Person: HYLAND ROSEMARY G. (EVP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-19 | Common Stock | M | 1300 | $37.28 | Acquired | 10084.98 | Direct |
| 2015-02-19 | Common Stock | F | 915 | $53.02 | Disposed | 9169.98 | Direct |
| 2015-02-19 | Common Stock | F | 97 | $53.02 | Disposed | 9072.98 | Direct |
| 2015-02-19 | Common Stock | M | 1196 | $41.71 | Acquired | 10268.98 | Direct |
| 2015-02-19 | Common Stock | F | 103 | $53.02 | Disposed | 10165.98 | Direct |
| 2015-02-19 | Common Stock | F | 941 | $53.02 | Disposed | 9224.98 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-19 | Incentive Stock Option (Right to Buy) | $37.28 | M | 1300 | Disposed | 2017-11-29 | Common Stock (1300) | Direct |
| 2015-02-19 | Stock Appreciation Rights (SAR) | $41.71 | M | 1196 | Disposed | 2019-09-17 | Common Stock (1196) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1506.53 | Indirect |
| Common Stock | 1330.71 | Indirect |
Footnotes
F1: Shares withheld for Option Cost.
F2: Shares withheld for taxes.
F3: Deemed disposition of shares to the issuer to satisfy exercise price.
F4: The stock option becomes exercisable in six annual installments commencing two years after the date of grant.
F5: Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.